CorMedix Inc
F:19KA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CorMedix Inc
F:19KA
|
US |
|
H
|
HALEON PLC
F:H6D
|
UK |
|
S
|
Schibsted ASA
XMUN:XPG
|
NO |
|
BOK Financial Corp
F:BJR
|
US |
|
K
|
Kosmos Energy Ltd
LSE:KOS
|
US |
|
J
|
JCDecaux SA
F:DCS
|
FR |
|
E
|
Electronic Arts Inc
XBER:ERT
|
US |
|
R
|
Rusta AB (publ)
STO:RUSTA
|
SE |
|
F
|
Fanuc Corp
F:FUC
|
JP |
|
A
|
Avis Budget Group Inc
F:CUCA
|
US |
|
C
|
CenterPoint Energy Inc
XMUN:HOU
|
US |
|
Ageas SA
OTC:AGESF
|
BE |
Wall St Price Targets
19KA Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for 19KA is 19.456 EUR with a low forecast of 16.697 EUR and a high forecast of 25.369 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19KA's stock price target?
Price Target
19.456
EUR
According to Wall Street analysts, the average 1-year price target for 19KA is 19.456 EUR with a low forecast of 16.697 EUR and a high forecast of 25.369 EUR.
What is the Revenue forecast for CorMedix Inc?
Projected CAGR
15%
The compound annual growth rate for Revenue over the next 8 years is 15%.
What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
20%
The compound annual growth rate for Operating Income over the next 8 years is 20%.
What is the Net Income forecast for CorMedix Inc?
Projected CAGR
13%
The compound annual growth rate for Net Income over the next 8 years is 13%.
